ember 3 issue of the Journal of Clinical Investigation, Steven Ziegler and colleagues from the Benaroya Research Institute in Seattle report that CD25-CD4+ T cells produced in the thymus can differentiate to Foxp3-expressing CD25+CD4+ T regulatory cells in the periphery and are capable of suppressing the activation and expansion of self-reactive T cells that may cause autoimmune disease. The report suggests an active role for Foxp3 in suppressing self-directed immune responses and a therapeutic role for Foxp3 in the treatment of autoimmune diseases.
In an accompanying commentary in the same issue, Shimon Sakaguchi from Kyoto University, Japan, discusses the developmental pathway of Foxp3-expressing T regulatory cells and their role in controlling self-tolerance and autoimmunity.
TITLE: Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+Cd25- T cells.
Steven F. Ziegler
Benaroya Research Institute, Seattle, Washington, USA.
View the PDF of this article at: https://www.the-jci.org/press/19441.pdf
The origin of FOXP3-expressing CD4+ regulatory T cells: thymus or periphery
Institute for Frontier Medical Sciences, Kyoto University, Kyoto, Japan.
View the PDF of this commentary at: https://www.the-jci.org/press/20274.pdf
Stopping bone loss during lactation
Parathyroid horPage: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Related biology news :1
Contact: Brooke Grindlinger
Journal of Clinical Investigation
. JCI Table of Contents, 15 July 20042
. JCI Table of Contents, January 15 20043
. JCI Table of Contents, 1 October, 20034
. JCI Table of Contents, September 15, 20035
. JCI Table of Contents6
. JCI Table of Contents, 15 August 20037
. JCI Table of Contents, May 1, 20038
. JCI Table of Contents, April 1, 20039
. JCI Table of Contents, March 14, 200310
. JCI Table of Contents, January 2, 200311
. JCI Table of Contents, December 2, 2002